Clinical Trials Sponsored by Institute of Medical Biology, Chinese Academy of Medical Sciences

Total 2954 results

Cancer Institute and Hospital, Chinese Academy...

Recruiting

Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study

Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors

Neoplasms

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Breast Cancer | Triple Negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules

Adenocarcinoma of Lung
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Pancreatic Cancer | Capecitabine | Radiotherapy | Envafolimab

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma (Siewert II-III)

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

Malignant Solid Tumors
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients

Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

NV-001 in the Treatment of Advanced Solid Tumors

Malignant Neoplasm

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation

Indocyanine Green | Fluorescence | Rectal Cancer Surgery

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC (NeoR-World)

Non-Small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy (HN)

Head and Neck Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Chemotherapy Effect | Locally Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor

Neuroendocrine Tumor

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins

Malignancy

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal Cancer

Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Esophageal Cancer | Patient-controlled Analgesia | NSAIDs | Perioperative Analgesia | Opioid

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer

Gastric Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Carcinoma, Transitional Cell | HER-2 Gene Amplification

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Nausea | Vomiting | Head and Neck Squamous Cell Carcinoma | Radiotherapy Side Effect

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Mesothelioma, Malignant | Mesothelioma, Malignant Pleural | Mesothelioma Malignant Advanced

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer

HER2-positive Breast Cancer
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

Colo-rectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Real World Study of MPM in China

Diagnoses Disease | Malignant Pleural Mesothelioma | Prognosis | Treatments

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

Extensive-stage Small-cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis

Patients With Resectable Hepatocellular Carcinoma Who Are at High Risk of Recurrence or Metastasi

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

HNSCC

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

Oligometastatic Disease | Immunotherapy | Esophagus Cancer | Chemoradiotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Small-cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer

NSCLC
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Chemoradiotherapy in Unresectable Esophageal Cancer

Esophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | Albumin-bound Paxlitaxel

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

Esophageal Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Triple Negative Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Cancer Institute and Hospital, Chinese Academy...

Recruiting

MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer (SUNRISE)

Rectal Neoplasms

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer (STELLAR)

Cancer, Rectum

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma

Esophageal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients

Metastatic Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma (SIRAHCC)

Hepatocellular Carcinoma, Radiotherapy, Sorafenib

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC

Hepatocellular Carcinoma | Radiotherapy | Lenvatinib

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC (LEO)

Esophageal Squamous Cell Carcinoma | Oligometastatic Disease

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

Small-cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma

Hypopharyngeal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

To Evaluate the Efficacy and Safety of Anlotinib Combined With Allitinib in Lung Cancer

Lung Cancer
Cancer Institute and Hospital, Chinese Academy...

Unknown

Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy

Brain Death | Coma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Small-cell Lung Cancer

China

Clinical Trials Sponsored by Institute of Medical Biology, Chinese Academy of Medical Sciences

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations